These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 32236582

  • 21. The diagnostic and prognostic relevance of human telomerase reverse transcriptase mRNA expression detected in situ in patients with nonsmall cell lung carcinoma.
    Fujita Y, Fujikane T, Fujiuchi S, Nishigaki Y, Yamazaki Y, Nagase A, Shimizu T, Ohsaki Y, Kikuchi K.
    Cancer; 2003 Sep 01; 98(5):1008-13. PubMed ID: 12942569
    [Abstract] [Full Text] [Related]

  • 22. Gene expression and prognosis of insulin‑like growth factor‑binding protein family members in non‑small cell lung cancer.
    Wang J, Hu ZG, Li D, Xu JX, Zeng ZG.
    Oncol Rep; 2019 Nov 01; 42(5):1981-1995. PubMed ID: 31545451
    [Abstract] [Full Text] [Related]

  • 23. Clinical Significance and Tumor-Suppressive Function of miR-516b in Nonsmall Cell Lung Cancer.
    Zhu J, Zhang Y, Yang X, Jin L.
    Cancer Biother Radiopharm; 2017 May 01; 32(4):115-123. PubMed ID: 28514208
    [Abstract] [Full Text] [Related]

  • 24. A meta-analysis for CXCR4 as a prognostic marker and potential drug target in non-small cell lung cancer.
    Zhang C, Li J, Han Y, Jiang J.
    Drug Des Devel Ther; 2015 May 01; 9():3267-78. PubMed ID: 26150700
    [Abstract] [Full Text] [Related]

  • 25. Decreased expression of connective tissue growth factor in non-small cell lung cancer is associated with clinicopathological variables and can be restored by epigenetic modifiers.
    Drzewiecka H, Gałęcki B, Jarmołowska-Jurczyszyn D, Kluk A, Dyszkiewicz W, Jagodziński PP.
    J Cancer Res Clin Oncol; 2016 Sep 01; 142(9):1927-46. PubMed ID: 27393180
    [Abstract] [Full Text] [Related]

  • 26. Interferon regulatory factor 4 (IRF4) is overexpressed in human non‑small cell lung cancer (NSCLC) and activates the Notch signaling pathway.
    Qian Y, Du Z, Xing Y, Zhou T, Chen T, Shi M.
    Mol Med Rep; 2017 Nov 01; 16(5):6034-6040. PubMed ID: 28849037
    [Abstract] [Full Text] [Related]

  • 27. Overexpressed LAPTM4B-35 is a risk factor for cancer recurrence and poor prognosis in non-small-cell lung cancer.
    Kong F, Gao F, Chen J, Sun Y, Zhang Y, Liu H, Li X, Yang P, Zheng R, Liu G, Jia Y.
    Oncotarget; 2016 Aug 30; 7(35):56193-56199. PubMed ID: 27486880
    [Abstract] [Full Text] [Related]

  • 28. MicroRNA-383 is a tumor suppressor and potential prognostic biomarker in human non-small cell lung caner.
    Shang Y, Zang A, Li J, Jia Y, Li X, Zhang L, Huo R, Yang J, Feng J, Ge K, Yang Y, Zhang Y, Jiang J.
    Biomed Pharmacother; 2016 Oct 30; 83():1175-1181. PubMed ID: 27551765
    [Abstract] [Full Text] [Related]

  • 29. SATB1 Level Correlates with Ki-67 Expression and Is a Positive Prognostic Factor in Non-small Cell Lung Carcinoma.
    Glatzel-Plucinska N, Piotrowska A, Grzegrzolka J, Olbromski M, Rzechonek A, Dziegiel P, Podhorska-Okolow M.
    Anticancer Res; 2018 Feb 30; 38(2):723-736. PubMed ID: 29374696
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Association of FOSB exon 4 unmethylation with poor prognosis in patients with late‑stage non‑small cell lung cancer.
    Kim DS, Lee WK, Park JY.
    Oncol Rep; 2020 Feb 30; 43(2):655-661. PubMed ID: 31894310
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Prognostic significance of TAZ expression in resected non-small cell lung cancer.
    Xie M, Zhang L, He CS, Hou JH, Lin SX, Hu ZH, Xu F, Zhao HY.
    J Thorac Oncol; 2012 May 30; 7(5):799-807. PubMed ID: 22481233
    [Abstract] [Full Text] [Related]

  • 36. Decreased microRNA-224 and its clinical significance in non-small cell lung cancer patients.
    Zhu D, Chen H, Yang X, Chen W, Wang L, Xu J, Yu L.
    Diagn Pathol; 2014 Nov 19; 9():198. PubMed ID: 25410592
    [Abstract] [Full Text] [Related]

  • 37. Co-downregulation of PTEN, KAI-1, and nm23-H1 tumor/metastasis suppressor proteins in non-small cell lung cancer.
    Goncharuk VN, del-Rosario A, Kren L, Anwar S, Sheehan CE, Carlson JA, Ross JS.
    Ann Diagn Pathol; 2004 Feb 19; 8(1):6-16. PubMed ID: 15129904
    [Abstract] [Full Text] [Related]

  • 38. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH, Wang SF, Yu L, Wang J, Chang H, Yan WL, Zhang J, Fu K.
    Lung Cancer; 2008 Oct 19; 62(1):113-9. PubMed ID: 18550205
    [Abstract] [Full Text] [Related]

  • 39. Expression of DR5 and c‑FLIP proteins as novel prognostic biomarkers for non‑small cell lung cancer patients treated with surgical resection and chemotherapy.
    Zheng H, Zhang Y, Zhan Y, Liu S, Lu J, Wen Q, Fan S.
    Oncol Rep; 2019 Dec 19; 42(6):2363-2370. PubMed ID: 31638235
    [Abstract] [Full Text] [Related]

  • 40. Down-regulation of miR-503 expression predicate advanced mythological features and poor prognosis in patients with NSCLC.
    Liu L, Qu W, Zhong Z.
    Int J Clin Exp Pathol; 2015 Dec 19; 8(5):5609-13. PubMed ID: 26191272
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.